Celcuity Inc., a clinical-stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company's lead drug candidate includes Gedatolisib, which selectively targets various Class I isoforms of...
14 insider purchases on record · latest filing 2025-09-10.
Insiders have also filed 57 sale transactions at CELC.